Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-17 | New | $100,000 | $100,000 | Debt Only | 06b | SEC link |
| 2022-02-23 | New | $1,049,456 | $1,049,456 | Equity Only | 06b | SEC link |
| 2020-03-31 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2018-09-21 | New | $2,110,200 | $2,110,200 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David S Alburty | Director, Executive |
| Paul S Bertrand | Director |
| Michael Heckman | Director |
| Andrew E Page | Director, Executive |
| Carol A Pranulis | Director |
| Kathleen Ruegsegger | Director, Executive |